DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories Limited
02 1SMS Pharmaceuticals Limited
01 1ROSIGLITAZONE MALEATE
02 1Rosiglitazone Maleate
01 2India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-063
Start Marketing Date : 2011-09-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 67835-0012
Start Marketing Date : 2015-05-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Rosiglitazone Maleate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rosiglitazone Maleate, including repackagers and relabelers. The FDA regulates Rosiglitazone Maleate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rosiglitazone Maleate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rosiglitazone Maleate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rosiglitazone Maleate supplier is an individual or a company that provides Rosiglitazone Maleate active pharmaceutical ingredient (API) or Rosiglitazone Maleate finished formulations upon request. The Rosiglitazone Maleate suppliers may include Rosiglitazone Maleate API manufacturers, exporters, distributors and traders.
click here to find a list of Rosiglitazone Maleate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rosiglitazone Maleate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rosiglitazone Maleate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rosiglitazone Maleate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rosiglitazone Maleate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rosiglitazone Maleate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rosiglitazone Maleate suppliers with NDC on PharmaCompass.
We have 2 companies offering Rosiglitazone Maleate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
